Poster abstracts
Poster number 16 submitted by Lydia Phillips
Targeting intronic RNA sequences with modified antisense oligonucleotides to boost gene expression
Lydia Phillips (Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213), Julie Bove (Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213; Ray and Stephanie Lane Computational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213), Dervla Moore-Frederick, Nic Fitzgerald (Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213), Willough Sloan, Subhasish Panda (Department of Chemistry, Carnegie Mellon University, Pittsburgh, PA 15213), Dr. Subha R. Das (Department of Chemistry, Carnegie Mellon University, Pittsburgh, PA 15213), Dr. Jon E. Henninger (Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213)
Abstract:
Targeting intronic RNA sequences with modified antisense oligonucleotides to boost gene expression
Intronic sequences encompass the vast majority of sequence content of pre-messenger RNA molecules, providing a rich, untapped source for therapeutic targets. Most introns are removed from RNA near their site of transcription, which creates a target source enriched near active transcriptional processes while preventing off-target binding to and disruption of mature messenger RNAs (mRNAs). Here, we provide evidence that conserved intronic RNA elements serve as tunable regulators of gene output. Using a blanketing approach, we targeted highly conserved sequences in introns with small, chemically modified antisense oligonucleotides (ASOs). Remarkably, targeting such sequences in three genes – GATA2, RUNX1, and HNF4A – whose monoallelic loss is associated with cancer or tissue dysfunction in hematopoietic and hepatic cells, increased levels of their mature mRNA products by 1.5-6 fold. Targeting non-conserved regions of the same RNAs or using the reverse complement sequence did not show this effect. Single ASOs capable of boosting expression showed dose-dependent activation of target genes and concomitant increases in protein levels. We will discuss experimental efforts to identify the mechanism of action. Together, our results reveal intronic sequences as rich target sources to potentially tune transcription and provide a method to stimulate production of haploinsufficient proteins from their remaining healthy allele. Such modest allele boosting could restore proper gene expression to physiological levels and rejuvenate cellular function in cancer and degenerative disease.
Keywords: gene regulation, antisense oligonucleotides (ASOs), conserved introns
